Literature DB >> 28586301

Definition of the upper reference limit of glycated albumin in blood donors from Italy.

Chiara Bellia1, Martina Zaninotto1, Chiara Cosma1, Luisa Agnello1, Bruna Lo Sasso1, Giulia Bivona1, Mario Plebani1, Marcello Ciaccio1.   

Abstract

BACKGROUND: Glycated Albumin (GA) has been proposed as a short-term indicator of glycemic homeostasis. The aim of this study is to describe the distribution of GA in a large sample of blood donors from Italy to evaluate whether demographic features, namely age and sex, could influence GA levels and define specific reference limits.
METHODS: The study included 1334 Italian blood donors. GA was measured using an enzymatic method (quantILab Glycated Albumin, IL Werfen, Germany). The upper reference limit (URL) was calculated using the non-parametric percentile method.
RESULTS: A modest, although significant, increase of GA was observed in relation to age (p<0.001), especially in males, where the differences were more pronounced (p<0.001 in males, p=0.003 in females). Slight differences were documented based on sex (12% [11.3-12.8] in males; 12.2% [11.4-13.1] in females; p=0.01). After excluding individuals with fasting plasma glucose ≥7 mmol/L, the calculated GA URL was 14.5% (95% CI: 14.3-14.7). Subjects with GA>14.5% presented a mean age of 48.4±12.2 years, 66.7% were males and the mean glucose was 6.88±2.5 mmol/L.
CONCLUSIONS: GA in Caucasians shows a similar increasing trend at older ages documented in other ethnicities. The definition of the URL in this population could be useful for both clinical studies, which will clarify the role of GA for diagnosing and monitoring diabetes, and will encourage the introduction of GA in clinical practice.

Entities:  

Keywords:  blood donors; diabetes; glycated albumin; reference limit

Mesh:

Substances:

Year:  2017        PMID: 28586301     DOI: 10.1515/cclm-2017-0179

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  11 in total

1.  Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.

Authors:  Elizabeth Selvin; Bethany Warren; Xintong He; David B Sacks; Amy K Saenger
Journal:  Clin Chem       Date:  2018-02-07       Impact factor: 8.327

Review 2.  Vitamin D and Genetic Susceptibility to Multiple Sclerosis.

Authors:  Concetta Scazzone; Luisa Agnello; Giulia Bivona; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Genet       Date:  2020-11-07       Impact factor: 1.890

Review 3.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

4.  Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.

Authors:  Elena Dozio; Valentina Corradi; Elena Vianello; Elisa Scalzotto; Massimo de Cal; Massimiliano Marco Corsi Romanelli; Claudio Ronco
Journal:  Mediators Inflamm       Date:  2017-09-25       Impact factor: 4.711

5.  Establishing the upper reference limit of Galectin-3 in healthy blood donors.

Authors:  Luisa Agnello; Chiara Bellia; Bruna Lo Sasso; Alessia Pivetti; Maddalena Muratore; Concetta Scazzone; Giulia Bivona; Giuseppe Lippi; Marcello Ciaccio
Journal:  Biochem Med (Zagreb)       Date:  2017-10-15       Impact factor: 2.313

6.  Establishment of thromboelastography reference intervals by indirect method and relevant factor analyses.

Authors:  Daye Cheng; Xiaoying Li; Shuo Zhao; Yiwen Hao
Journal:  J Clin Lab Anal       Date:  2020-01-31       Impact factor: 2.352

7.  Establishing the 99th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy.

Authors:  Luisa Agnello; Chiara Bellia; Concetta Scazzone; Giulia Bivona; Giorgia Iacolino; Caterina Maria Gambino; Maddalena Muratore; Bruna Lo Sasso; Marcello Ciaccio
Journal:  Biochem Med (Zagreb)       Date:  2019-06-15       Impact factor: 2.313

Review 8.  Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases.

Authors:  Rosaria Vincenza Giglio; Bruna Lo Sasso; Luisa Agnello; Giulia Bivona; Rosanna Maniscalco; Daniela Ligi; Ferdinando Mannello; Marcello Ciaccio
Journal:  J Clin Med       Date:  2020-11-11       Impact factor: 4.241

9.  Association of Glycated Albumin/Glycosylated Hemoglobin Ratio with Blood Glucose Fluctuation and Long-Term Blood Glucose Control in Patients with Type 2 Diabetes Mellitus.

Authors:  Bai-Rong Wang; Jun-Teng Yao; Hui Zheng; Quan-Min Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-27       Impact factor: 3.168

10.  Unstably controlled systolic blood pressure trajectories are associated with markers for kidney damage in prediabetic population: results from the INDEED cohort study.

Authors:  Zi-Jun Sun; Jin-Wei Wang; Dong-Yuan Chang; Shuo-Hua Chen; Hui-Fen Zhang; Shou-Ling Wu; Kevin He; Lu-Xia Zhang; Min Chen; Ming-Hui Zhao
Journal:  J Transl Med       Date:  2020-05-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.